These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19865181)

  • 1. A new PG13-based packaging cell line for stable production of clinical-grade self-inactivating gamma-retroviral vectors using targeted integration.
    Loew R; Meyer Y; Kuehlcke K; Gama-Norton L; Wirth D; Hauser H; Stein S; Grez M; Thornhill S; Thrasher A; Baum C; Schambach A
    Gene Ther; 2010 Feb; 17(2):272-80. PubMed ID: 19865181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the piggyBac transposon to create stable packaging cell lines for the production of clinical-grade self-inactivating γ-retroviral vectors.
    Feldman SA; Xu H; Black MA; Park TS; Robbins PF; Kochenderfer JN; Morgan RA; Rosenberg SA
    Hum Gene Ther Methods; 2014 Aug; 25(4):253-60. PubMed ID: 25072603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HEK293-based production platform for γ-retroviral (self-inactivating) vectors: application for safe and efficient transfer of COL7A1 cDNA.
    Hennig K; Raasch L; Kolbe C; Weidner S; Leisegang M; Uckert W; Titeux M; Hovnanian A; Kuehlcke K; Loew R
    Hum Gene Ther Clin Dev; 2014 Dec; 25(4):218-28. PubMed ID: 25381930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new generation of retroviral producer cells: predictable and stable virus production by Flp-mediated site-specific integration of retroviral vectors.
    Schucht R; Coroadinha AS; Zanta-Boussif MA; Verhoeyen E; Carrondo MJ; Hauser H; Wirth D
    Mol Ther; 2006 Aug; 14(2):285-92. PubMed ID: 16697259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disclosing the Parameters Leading to High Productivity of Retroviral Producer Cells Lines: Evaluating Random Versus Targeted Integration.
    Bandeira VS; Tomás HA; Alici E; Carrondo MJ; Coroadinha AS
    Hum Gene Ther Methods; 2017 Apr; 28(2):78-90. PubMed ID: 28301970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient construction of producer cell lines for a SIN lentiviral vector for SCID-X1 gene therapy by concatemeric array transfection.
    Throm RE; Ouma AA; Zhou S; Chandrasekaran A; Lockey T; Greene M; De Ravin SS; Moayeri M; Malech HL; Sorrentino BP; Gray JT
    Blood; 2009 May; 113(21):5104-10. PubMed ID: 19286997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroviral vector performance in defined chromosomal Loci of modular packaging cell lines.
    Gama-Norton L; Herrmann S; Schucht R; Coroadinha AS; Löw R; Alves PM; Bartholomae CC; Schmidt M; Baum C; Schambach A; Hauser H; Wirth D
    Hum Gene Ther; 2010 Aug; 21(8):979-91. PubMed ID: 20222806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of recombinase mediated cassette exchange in retroviral vector producer cell lines: predictability and efficiency by transgene exchange.
    Coroadinha AS; Schucht R; Gama-Norton L; Wirth D; Hauser H; Carrondo MJ
    J Biotechnol; 2006 Jul; 124(2):457-68. PubMed ID: 16529836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Packaging cell line characteristics and optimizing retroviral vector titer: the National Gene Vector Laboratory experience.
    Reeves L; Smucker P; Cornetta K
    Hum Gene Ther; 2000 Oct; 11(15):2093-103. PubMed ID: 11044911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated strategy for the production of therapeutic retroviral vectors.
    Carrondo M; Panet A; Wirth D; Coroadinha AS; Cruz P; Falk H; Schucht R; Dupont F; Geny-Fiamma C; Merten OW; Hauser H
    Hum Gene Ther; 2011 Mar; 22(3):370-9. PubMed ID: 21043806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiency.
    van der Loo JC; Swaney WP; Grassman E; Terwilliger A; Higashimoto T; Schambach A; Hacein-Bey-Abina S; Nordling DL; Cavazzana-Calvo M; Thrasher AJ; Williams DA; Reeves L; Malik P
    Gene Ther; 2012 Aug; 19(8):872-6. PubMed ID: 22551777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene.
    Persons DA; Mehaffey MG; Kaleko M; Nienhuis AW; Vanin EF
    Blood Cells Mol Dis; 1998 Jun; 24(2):167-82. PubMed ID: 9642098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Safety of retroviral vectors in gene therapy].
    Bogoslovskaia EV; Glazkova DV; Shipulin GA; Pokrovskiĭ VV
    Vestn Ross Akad Med Nauk; 2012; (10):55-61. PubMed ID: 23240501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of High-Titer Self-Inactivated γ-Retroviral Vector Producer Cells.
    Ghani K; Boivin-Welch M; Roy S; Dakiw-Piaceski A; Barbier M; Pope E; Germain L; Caruso M
    Mol Ther Methods Clin Dev; 2019 Sep; 14():90-99. PubMed ID: 31312667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and production of retro- and lentiviral vectors for gene expression in hematopoietic cells.
    Schambach A; Swaney WP; van der Loo JC
    Methods Mol Biol; 2009; 506():191-205. PubMed ID: 19110628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of retroviral vector design in defined chromosomal loci by Flp-mediated cassette replacement.
    Verhoeyen E; Hauser H; Wirth D
    Hum Gene Ther; 2001 May; 12(8):933-44. PubMed ID: 11387058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccinia viral/retroviral chimeric vectors.
    Falkner FG; Holzer GW
    Curr Gene Ther; 2004 Dec; 4(4):417-26. PubMed ID: 15578991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Green fluorescent protein retroviral vectors: low titer and high recombination frequency suggest a selective disadvantage.
    Hanazono Y; Yu JM; Dunbar CE; Emmons RV
    Hum Gene Ther; 1997 Jul; 8(11):1313-9. PubMed ID: 9295126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of methods for somatic cell gene therapy directed against viral diseases, using retroviral vectors carrying the murine or human interferon-beta coding sequence: establishment of the antiviral state in human cells.
    Lauret E; Riviere I; Rousseau V; Vieillard V; De Maeyer-Guignard J; De Maeyer E
    Hum Gene Ther; 1993 Oct; 4(5):567-77. PubMed ID: 8280795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroviruses as vectors.
    Vile RG; Russell SJ
    Br Med Bull; 1995 Jan; 51(1):12-30. PubMed ID: 7767638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.